BioSAXS-an emerging method to accelerate, enrich and de-risk antimicrobial drug development

• Egile Nagusiak: Christoph Rumancev (Egilea), Axel Rosenhahn (Egilea), Kai Hilpert (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Antimicrobial resistance is a worldwide threat to modern health care. Low-profit margin and high risk of cross-resistance resulted in a loss of interest in big pharma, contributing to the increasing threat. Strategies to address the problem are starting to emerge. Novel antimicrobial compounds with...